KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

KORU Medical Systems, Inc.NASDAQ: KRMD

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue grows in line with its trailing trend

Q1 FY2026 revenue of $11.76M rose 22.1% year over year, behind the +23.3% change in trailing-twelve-month revenue. Sequentially, it rose 8.0% from the prior quarter. Over 3 fiscal years it compounded at +13.8% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 3 analysts of $48.22M (+17.2%) for the fiscal year ending Dec 2026, a slowdown from the +22.2% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$11.76M+8.0% QoQ
Last fiscal yearDec 2025
$41.13M+22.2% YoY
LTMMar 2026
$43.26M+23.3% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+22.1%+14.0%-8.1 pp
1 year+22.2%+17.2%-5.0 pp
3-year CAGR+13.8%+16.4%+2.6 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
41.13M USD
Year-over-year change
+22.2%
4-year CAGR
+15.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How KRMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +23.3% is the 6th highest of 10, against a peer median of +34.8%.
  • Over three fiscal years its annual growth of +13.8% compares with a peer median of +31.8%.
KRMD Competitors
Revenue for KRMD and competitors
Company Period LTM YoY 3-year CAGR
STIMNeuronetics, Inc.LTM Mar 2026$151.64M USD+69.5%+31.8%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$142.4M USD+3.5%+9.3%
PREPrenetics Global LimitedLTM Mar 2026$113.75M USD+174.0%+91.5%
OSUROraSure Technologies, Inc.LTM Mar 2026$113.02M USD-30.1%-33.3%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$44.88M USD+39.6%+53.9%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$43.26M USD+23.3%+13.8%
UTMDUtah Medical Products, Inc.LTM Mar 2026$37.53M USD-4.4%-9.7%
MXCTMaxCyte, Inc.LTM Mar 2026$32.29M USD-14.3%-9.3%
PROFProfound Medical Corp.LTM Mar 2026$18.87M USD+34.8%+34.8%
NYXHNyxoah S.A.LTM Mar 2026€16.32M EUR+273.9%+48.1%
Peer median (excluding KRMD) —+34.8%+31.8%

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue23.49M27.9M28.52M33.65M41.13M
Cost of Revenue9.72M12.53M11.81M12.31M15.52M
Gross Profit13.77M15.37M16.71M21.33M25.6M
Gross Margin58.6%55.1%58.6%63.4%62.3%
Research & Development2.47M4.96M5.74M5.26M4.39M
Selling, General & Admin000023.38M
Operating Expenses20.8M26.15M26.98M27.78M28.58M
Depreciation & Amortization463.13K587.14K870.39K772.89K810.5K
EBITDA(5.9M)(10.09M)(8.9M)(5.29M)(1.81M)
EBITDA Margin-25.1%-36.2%-31.2%-15.7%-4.4%
Operating Income(7.03M)(10.78M)(10.27M)(6.45M)(2.97M)
Operating Margin-29.9%-38.6%-36.0%-19.2%-7.2%
Interest Income13.08K145.59K561.33K444.64K293.4K
Interest Expense00000
Other Income / Expenses665.09K105.71K496.4K382.49K356.41K
Income Before Tax(6.36M)(10.68M)(9.77M)(6.06M)(2.62M)
Pre-Tax Margin-27.1%-38.3%-34.3%-18.0%-6.4%
Income Tax Expense(1.8M)(2.01M)3.97M2.89K21.89K
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Net Margin-19.4%-31.0%-48.2%-18.0%-6.4%
EPS (Basic)(0.10)(0.19)(0.30)(0.13)(0.06)
EPS (Diluted)(0.10)(0.19)(0.30)(0.13)(0.06)
Weighted Avg Shares44.39M45M45.6M45.8M46.19M
Weighted Avg Shares (Diluted)44.39M45M45.6M45.8M46.19M

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.